What Is Topiramate?
Topiramate is an anticonvulsant medication originally developed for epilepsy that's also FDA-approved for migraine prevention. It works through multiple mechanisms in the brain and may help with certain other pain conditions. Brand names include Topamax and Trokendi XR.1
How It Works2
- Multiple mechanisms of action
- Enhances GABA activity
- Blocks sodium channels
- Reduces glutamate activity
- Weak carbonic anhydrase inhibitor
Approved Uses
- Epilepsy
- Migraine prevention
Off-Label Pain Uses
- Chronic daily headache
- Cluster headache (sometimes)
- Neuropathic pain
- Fibromyalgia (mixed evidence)
Dosing3
- Start very low (25 mg/day)
- Increase slowly over weeks
- Target dose varies by condition
- Migraine: often 50-100 mg/day
- Slow titration reduces side effects
Common Side Effects
- Cognitive effects ("foggy thinking")
- Word-finding difficulty
- Tingling in hands/feet
- Fatigue
- Nausea
- Taste changes
- Weight loss (can be benefit or problem)
- Appetite suppression
Serious Risks
- Kidney stones
- Metabolic acidosis
- Acute glaucoma (rare emergency)
- Overheating (reduced sweating)
- Birth defects (avoid in pregnancy)
- Suicidal thoughts (rare)
Important Precautions
- Stay well hydrated (prevents stones)
- Effective birth control essential
- Avoid in liver/kidney disease
- Can interact with birth control pills
- Monitor for eye problems
Who Might Consider
- Frequent migraines needing prevention
- Especially if weight loss desired
- Failed other preventives
- Co-existing epilepsy
Who Should Avoid
- Pregnant or planning pregnancy
- History of kidney stones
- Glaucoma
- Cognitive jobs requiring word fluency
References
- Silberstein SD, Neto W, Schmitt J, Jacobs D. Topiramate in migraine prevention: results of a large controlled trial. Arch Neurol. 2004;61(4):490-495.
- Shank RP, Gardocki JF, Streeter AJ, Maryanoff BE. An overview of the preclinical aspects of topiramate. Epilepsia. 2000;41(Suppl 1):S3-9.
- Bussone G, Diener HC, Pfeil J, Schwalen S. Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trials. Int J Clin Pract. 2005;59(8):961-968.